<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04987359</url>
  </required_header>
  <id_info>
    <org_study_id>2021-013</org_study_id>
    <nct_id>NCT04987359</nct_id>
  </id_info>
  <brief_title>A Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer</brief_title>
  <acronym>Small Steps</acronym>
  <official_title>A Randomized Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To examine the efficacy of a 10-week multimodal lifestyle program, versus waitlist control,&#xD;
      on cardiorespiratory fitness capacity and body weight in survivors of cancer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cardiorespiratory fitness capacity (co-primary)</measure>
    <time_frame>Baseline, Week 10</time_frame>
    <description>Cardiorespiratory fitness (VO2peak) assessed by a symptom-limited cardiopulmonary exercise test.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in body weight (co-primary)</measure>
    <time_frame>Baseline, Week 10</time_frame>
    <description>Bodyweight assessed using a digital scale in a fasting state with an empty bladder, without shoes, and only wearing light clothing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in waist Circumference</measure>
    <time_frame>Baseline, Week 10</time_frame>
    <description>Measured midway between the lower rib margin and the iliac crest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fat Mass</measure>
    <time_frame>Baseline, Week 10</time_frame>
    <description>Measured by dual-energy x-ray absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in systolic blood pressure</measure>
    <time_frame>Baseline, Week 10</time_frame>
    <description>Seating, resting for 5 minutes before the measure is taken</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in diastolic blood pressure</measure>
    <time_frame>Baseline, Week 10</time_frame>
    <description>Seating, resting for 5 minutes before the measure is taken</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in medication use</measure>
    <time_frame>Baseline, Week 10</time_frame>
    <description>Medications related to cholesterol, diabetes, and blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in physical and mental quality-of-life</measure>
    <time_frame>Baseline, Week 10</time_frame>
    <description>Assessed using the 36-Item Short Form Survey (SF-36)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Neoplasm Malignant</condition>
  <arm_group>
    <arm_group_label>Multimodal Lifestyle Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The multimodal lifestyle program will utilize intensive behavioral therapy with structured exercise training and nutritional counseling. The main objective of the structured exercise training is to improve cardiorespiratory fitness.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The waitlist control group will be asked to maintain their current exercise and dietary habits for the 10-week study period. Upon providing study endpoint data at week 10, control group participants will be offered a 4-week multimodal lifestyle program that is similar to the intervention group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Multimodal Lifestyle Program</intervention_name>
    <description>The multimodal lifestyle program will utilize intensive behavioral therapy with structured exercise training and nutritional counseling.</description>
    <arm_group_label>Multimodal Lifestyle Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ability to provide informed consent before any trial-related activities&#xD;
&#xD;
          -  History of any malignancy&#xD;
&#xD;
          -  Completion of cancer-directed therapy (e.g., surgery, chemotherapy, and radiotherapy)&#xD;
             prior to enrollment (patients receiving ongoing endocrine or targeted therapy are&#xD;
             eligible to participate)&#xD;
&#xD;
          -  No evidence of residual or recurrent cancer under active treatment&#xD;
&#xD;
          -  Age ≥18 years&#xD;
&#xD;
          -  Body mass index (BMI) ≥30 kg/m2 or BMI ≥27 kg/m2 with one or more treated or untreated&#xD;
             weight-related coexisting conditions&#xD;
&#xD;
          -  Willing to be randomized&#xD;
&#xD;
          -  Allow the collection and storage of biospecimens and data for future use&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Engaging in ≥3 purposeful exercise sessions per week, on average, over the past 12&#xD;
             weeks&#xD;
&#xD;
          -  Significant purposeful weight loss (&gt;11 kg) within the past 12 weeks&#xD;
&#xD;
          -  Current use of medications or devices for the purpose of weight loss&#xD;
&#xD;
          -  Metabolic or bariatric surgery within the last year&#xD;
&#xD;
          -  Cardiovascular, respiratory, or musculoskeletal disease that would prohibit&#xD;
             participation in an exercise and weight loss program&#xD;
&#xD;
          -  Currently pregnant, breastfeeding, or planning to become pregnant with the next 12&#xD;
             weeks&#xD;
&#xD;
          -  Psychiatric disorders or conditions that would preclude participation in the study&#xD;
             intervention&#xD;
&#xD;
          -  Any other condition which, in the opinion of the investigator, may impede testing of&#xD;
             the study hypothesis or make it unsafe to engage in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin C Brown, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tamara Green</last_name>
    <phone>225-763-2733</phone>
    <email>Tamara.Green@pbrc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamara Green</last_name>
      <phone>225-763-2733</phone>
      <email>Tamara.Green@pbrc.edu</email>
    </contact>
    <investigator>
      <last_name>Justin C Brown, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 13, 2021</study_first_submitted>
  <study_first_submitted_qc>August 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Justin Brown</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

